CASE REPORT article
Front. Pediatr.
Sec. Pediatric Nephrology
Acute Cyclosporine Overdose in a Child with Nephrotic Syndrome: A Case Report and Literature Review
Provisionally accepted
Eun Song Song1,2
Eun Mi Yang1,2*- 1Chonnam National University Medical School, Gwangju, Republic of Korea
- 2Chonnam National University Hospital, Dong-gu, Republic of Korea
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Calcineurin inhibitors are widely used in organ transplantation and nephrotic syndrome, with chronic toxicities well documented, but acute toxicity is rarely reported. Case presentation: We report a 3.9-year-old boy with steroid-dependent nephrotic syndrome who accidentally ingested a single dose of cyclosporine A (CsA) at 75 mg/kg (1,500 mg)— over 20 times the intended dose of 3.5 mg/kg (70mg) —due to medication error. He developed transient abdominal pain, diarrhea, and vomiting, which resolved without treatment. Error was discovered 12 hours post-ingestion, and he was hospitalized with a CsA trough level of 1003 ng/mL (measured 13 hours after ingestion), yet remained clinically stable. Management included CsA discontinuation, intravenous hydration, rifampin-and phenobarbital-induced cytochrome P450 activation, resulting in normalization of CsA levels within 48 hours. A literature review identified 28 pediatric cases of acute CsA overdose, with presentations ranging from asymptomatic to severe neurotoxicity and acute kidney injury. The varied, including supportive care, gastrointestinal decontamination, and enzyme induction, with generally favorable outcomes. Conclusions: Although rare, acute CsA overdose in children can pose serious risks. This case and review underscore the symptoms of overdose and prompt intervention to prevent complications.
Keywords: acute toxicity1, children2, Cyclosporine3, Nephrotic syndrome4, Treatment5
Received: 01 Nov 2025; Accepted: 02 Jan 2026.
Copyright: © 2026 Song and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Eun Mi Yang
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.